MEDIFY LTD

No Analysis Available

Get instant AI-powered insights about this company's financial health, risks, and trends.

Order Analysis - £10
Legal registered address
Suite Lp25360 20-22 Wenlock Road London England N1 7GU Copied!

Latest financial results as of 11 November 2025
Cash in bank
£1.24m
Current assets
£1.34m
Current creditors
£702.70k
Shareholders funds
£649.84k
View full financial accounts

Company number
08250800 Copied!
Company status
Active
Company type
Private Limited Company
Accounts category
Total Exemption Full
Incorporated on
12 October 2012
Accounts

Latest annual accounts were to 31 March 2024

Next annual accounts are due by 31 December 2025

Company financial year end is on 31 March 2026

Confirmation statement

Latest confirmation statement statement dated 10 October 2024

Next statement due by 24 October 2025

View original and historic source data
Nature of business (SIC)

63990 - Other information service activities not elsewhere classified

Latest company documents
DateDescription
24/10/2424 October 2024 Confirmation statement made on 2024-10-10 with updates

View Document

19/10/2419 October 2024 Resolutions

View Document

18/10/2418 October 2024 Cancellation of shares. Statement of capital on 2024-10-10

View Document

11/10/2411 October 2024 Cessation of Nicholas Rutherford as a person with significant control on 2024-10-11

View Document

11/10/2411 October 2024 Termination of appointment of Nicholas Rutherford as a director on 2024-10-11

View Document

View all company documents
AI-Powered Analysis for MEDIFY LTD

Get instant insights with Claude AI. Ask questions like:

  • "Is MEDIFY LTD financially stable?"
  • "What are the key risks for lending to this company?"
  • "Show me the director history and red flags"
Set Up AI Assistant

Takes 60 seconds • Works with Claude.ai


More Company Information

AI Company Analysis

Ask Claude AI about MEDIFY LTD:


Start Free Setup →

No downloads • 60 second setup


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company